Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,708,368 papers from all fields of science
Search
Sign In
Create Free Account
Adenovirus antibody (substance)
Known as:
Adenovirus Ab
, Adenovirus Antibody
, Anti-Adenovirus Antibody
An antibody produced by B-lymphocytes in response to adenovirus infection.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
10 relations
Adenovirus Ab:ACnc:Pt:Ser:Qn
Adenovirus Ab:Titr:Pt:Ser:Qn
Adenovirus Ab:Titr:Pt:Ser:Qn:Comp fix
Adenovirus Antigen
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Teriflunomide Does Not Significantly Affect Primary and Memory Antibody Responses to a Viral Antigen in Mice (P1.215)
A. Edling
,
L. Woodworth
,
+4 authors
J. Kaplan
Neurology
2014
Corpus ID: 70678859
OBJECTIVE: To assess the impact of teriflunomide on development of protective immune responses through measurement of antibody…
Expand
2010
2010
Preparation of a novel adenovirus formulation with artificial envelope of multilayer polymer-coatings: therapeutic effect on metastatic ovarian cancer.
C. Yoshihara
,
K. Hamada
,
Y. Koyama
Oncology Report
2010
Corpus ID: 31832890
Layer-by-layer deposition of the ionic polymers onto adenovirus particles afforded the multilayer-coated virus vectors. The…
Expand
2006
2006
A novel separation-free assay technique for serum antibodies using antibody bridging assay principle and two-photon excitation fluorometry.
J. Koskinen
,
J. Vaarno
,
R. Vainionpää
,
N. Meltola
,
A. Soini
JIM - Journal of Immunological Methods
2006
Corpus ID: 25153426
2006
2006
A multicenter phase I study of adenoviral p53 in Japanese patients with advanced non-small cell lung cancer.
S. Kagawa
,
T. Fujiwara
,
+6 authors
N. Tanaka
Journal of Clinical Oncology
2006
Corpus ID: 33423814
2564 Adenovirus expressing p53 gene, Advexin (A), has shown antitumor activity in a variety of human cancer in preclinical and…
Expand
2005
2005
[Detection of p53 gene change and serum antibody level in phase II clinical trial of ad p53 gene therapy].
Min Zhao
,
S. Xiao
,
Jing-xian Yang
,
Shan-wen Zhang
,
Y. Lü
Zhonghua yi xue za zhi
2005
Corpus ID: 27279379
OBJECTIVE To determine the alteration of p53 gene in tumor tissues and to monitor the immunoresponsiveness to anti adenovirus in…
Expand
1999
1999
Local adenovirus-mediated CTLA4-immunoglobulin expression suppresses the immune responses to adenovirus vectors in the brain
M. Ideguchi
,
K. Kajiwara
,
K. Yoshikawa
,
T. Uchida
,
H. Ito
Neuroscience
1999
Corpus ID: 46307320
1998
1998
Inhibitory effects of human sera on adenovirus-mediated gene transfer into rat liver.
Shigeki Kuriyama
,
K. Tominaga
,
+7 authors
Hiroshi Fukui
Anticancer Research
1998
Corpus ID: 37685216
Recent advances in molecular biology have made gene therapy for cancer feasible in clinical trials. Although recombinant…
Expand
1997
1997
Down‐regulation of CD95 (Fas/Apo‐1) in the epithelia of adenovirus‐infected appendices
F. Larousserie
,
D. Berrebi
,
A. Florentin
,
P. de Lagausie
,
Y. Aigrain
,
M. Peuchmaur
Histopathology
1997
Corpus ID: 37112132
Adenoviral inclusions are commonly seen in appendices from infants with intussusception. They are associated with focal…
Expand
1985
1985
Immunological and virological studies of patients with tumours of the urogenital system.
S. Csata
,
G. Kulcsár
,
+4 authors
J. Ongrádi
Acta chirurgica Hungarica
1985
Corpus ID: 43176794
The possible connections between the oncogenic viruses and the various tumours of the urogenital system were investigated…
Expand
1979
1979
Human adenovirus antibody in sera of normal and tumour-bearing dogs
W. D. Winters
The Veterinary Record
1979
Corpus ID: 1005646
Serum specimens from 42 normal dogs and 42 with untreated malignant tumours were assayed for the presence of antibodies to human…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE